|
2023
|
Invention
|
Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nuc... |
|
|
Invention
|
Human papillomavirus type 16 dna vaccine and use thereof. Disclosed are a human papillomavirus ty... |
|
|
Invention
|
Lipid compound for nucleic acid delivery, and related use and medicament comprising same. Provide... |
|
|
Invention
|
Class of lycorine derivatives, pharmaceutical composition thereof, and use thereof in preparation... |
|
|
Invention
|
Construct for real-time tracing of spatial genome conformation and transcription products in livi... |
|
|
Invention
|
Use of indanyl levulinate in prevention and/or treatment of muscle atrophy-related diseases. The ... |
|
|
Invention
|
Use of lithium-containing compounds in treatment of tumors. The present invention relates to the ... |
|
|
Invention
|
Molecular marker for red blood cell denucleation and use thereof. The present application relates... |
|
|
Invention
|
Small rna and use thereof in treatment of hyperlipidemia. Provided are small RNA and a use thereo... |
|
|
Invention
|
Small rna drug for inhibiting activity of cancer cells. Provided is a small RNA drug for inhibiti... |
|
|
Invention
|
Use of reagent for detecting retinol metabolite in preparation of tool for diagnosing and/or trea... |
|
2022
|
Invention
|
Spermine derivative and therapeutic use thereof for diseases. The present invention relates to a ... |
|
|
Invention
|
Use of spermine in preventing and treating inflammatory diseases. The present application relates... |
|
|
Invention
|
Novel compound cx-1 and therapeutic use thereof in inflammatory diseases and tumors. The present ... |
|
|
Invention
|
Use of tetrandrine in combination with all-trans retinoic acid in preparation of medicament for t... |
|
|
Invention
|
Use of glycerophospholipid compound in prevention and treatment of hyperlipidemia, atherosclerosi... |
|
|
Invention
|
Use of reagent for detecting eosinophil, eosinophil and cytoplasm content thereof, and hydroxy do... |
|
|
Invention
|
Use of fcgammariii inhibitor in preparation of medicament for treating pulmonary fibrosis.
The p... |
|
|
Invention
|
Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndr... |
|
|
Invention
|
Use of malic enzyme 2 in preparation of diagnostic reagent or medicament for silicosis or pulmona... |
|
|
Invention
|
1,2,3-triazolopyrimidine compound, preparation method therefor and use thereof. Disclosed are a c... |
|
|
Invention
|
Use of st-type lipid compounds in preparation of nucleic acid delivery reagent and related produc... |
|
|
Invention
|
Use of fa-type lipid compounds in preparation of nucleic acid delivery reagent and related produc... |
|
|
Invention
|
Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or... |
|
|
Invention
|
Polypeptide and polypeptide composition specifically binding to sars-cov-2 spike protein, and pre... |
|
|
Invention
|
Application of targeting agent of gasdermin e pathway in treatment of pancreatic cancer. The pres... |
|
|
Invention
|
Use of glycerophospholipid compounds in treatment of tumor. Use of glycerophospholipid compounds ... |
|
|
Invention
|
Use of cellular microparticles in treatment of respiratory viral pneumonia.
Disclosed is the use... |
|
|
Invention
|
Use of cellular microparticles in treatment of respiratory viral pneumonia. Disclosed is the use ... |
|
2021
|
Invention
|
Human papillomavirus type 18 chimeric protein and use thereof.
The present invention relates to ... |
|
|
Invention
|
Human papillomavirus type 31 chimeric protein and use thereof.
The present invention relates to ... |
|
|
Invention
|
Human papillomavirus type 58 chimeric protein and use thereof.
Provided are an HPV chimeric prot... |
|
|
Invention
|
Modified human papillomavirus type 52 l1 protein and use thereof.
The present application relate... |
|
|
Invention
|
C-terminus modified human papillomavirus type 6 l1 protein and use thereof.
The present applicat... |
|
|
Invention
|
C-terminally modified human papillomavirus type 11 l1 protein and use thereof.
The present appli... |
|
|
Invention
|
Human papillomavirus type 31 chimeric protein and use thereof. The present invention relates to a... |
|
|
Invention
|
Human papillomavirus type 58 chimeric protein and use thereof. Provided are an HPV chimeric prote... |
|
|
Invention
|
Human papillomavirus type 18 chimeric protein and use thereof. The present invention relates to a... |
|
|
Invention
|
Modified human papillomavirus type 52 l1 protein and use thereof. The present application relates... |
|
|
Invention
|
C-terminus modified human papillomavirus type 6 l1 protein and use thereof. The present applicati... |
|
|
Invention
|
C-terminally modified human papillomavirus type 11 l1 protein and use thereof. The present applic... |
|
|
Invention
|
Polypeptide that specifically binding to cd123 protein, polypeptide complexe, co-delivery system ... |
|
|
Invention
|
Antiviral use and broad-spectrum anti-inflammatory effect of lipid small molecule as 3c-like prot... |
|
2020
|
Invention
|
Use of lipid in preparation of nucleic acid delivery reagent and related product thereof.
Disclo... |
|
|
Invention
|
Heterogeneous stem cell population, preparation method therefor and use thereof.
Disclosed are a... |
|
2019
|
Invention
|
Cell-penetrating peptide based on influenza virus m2 protein.
Provided are a cell-penetrating pe... |
|
|
Invention
|
Anti-infection effects of hnrnpa2b1 and use thereof.
Provided are anti-infection effects of a he... |
